Adhesion proteins in the biology of breast cancer: Contribution of CD44

被引:86
作者
Herrera-Gayol, A [1 ]
Jothy, S [1 ]
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ, Canada
基金
英国医学研究理事会;
关键词
breast cancer; tumor marker; tumorigenesis; cell adhesion; diagnosis; prognosis;
D O I
10.1006/exmp.1999.2251
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
One of the most important features of tumor cell invasion is the ability to establish or modulate adhesion to other cells or to an extracellular matrix, a process mediated by a large number of adhesion proteins. This review examines how CD44 participates in malignant transformation and progression of the breast epithelium. CD44 is a family of cell adhesion glycoproteins generated by alternative splicing of up to 10 variant exons. Discrete CD44 isoforms are overexpressed in different human cancers, including breast cancer. Recent studies, including our own, have shown that CD44 is involved in two of the three steps of the invasive cascade: adhesion to the extracellular matrix and motility. The overexpression of one of the CD44 variants, CD44v6, is a significant component in the malignant transformation of the breast epithelium and its use as a prognostic marker is presently investigated. (C) 1999 Academic Press.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 65 条
[1]   PARTICIPATION IN NORMAL IMMUNE-RESPONSES OF A METASTASIS-INDUCING SPLICE VARIANT OF CD44 [J].
ARCH, R ;
WIRTH, K ;
HOFMANN, M ;
PONTA, H ;
MATZKU, S ;
HERRLICH, P ;
ZOLLER, M .
SCIENCE, 1992, 257 (5070) :682-685
[2]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[3]  
Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.0.CO
[4]  
2-0
[5]   ULTRASTRUCTURAL-STUDY ON PATHOGENICITY OF TRANSPLANTED TUMORS INVADING STRIATED MUSCULATURE [J].
BABAI, F .
JOURNAL OF ULTRASTRUCTURE RESEARCH, 1976, 56 (03) :287-303
[6]   MOLECULAR AND CELLULAR ANALYSIS OF BASEMENT-MEMBRANE INVASION BY HUMAN BREAST-CANCER CELLS IN MATRIGEL-BASED INVITRO ASSAYS [J].
BAE, SN ;
ARAND, G ;
AZZAM, H ;
PAVASANT, P ;
TORRI, J ;
FRANDSEN, TL ;
THOMPSON, EW .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) :241-255
[7]   Identification of CD44 residues important for hyaluronan binding and delineation of the binding site [J].
Bajorath, J ;
Greenfield, B ;
Munro, SB ;
Day, AJ ;
Aruffo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :338-343
[8]   Gains and losses of CD44 expression during breast carcinogenesis and tumour progression [J].
Bankfalvi, A ;
Terpe, HJ ;
Breukelmann, D ;
Bier, B ;
Rempe, D ;
Pschadka, G ;
Krech, R ;
Böcker, W .
HISTOPATHOLOGY, 1998, 33 (02) :107-116
[9]   INTERACTION BETWEEN CD44 AND HYALURONATE IS DIRECTLY IMPLICATED IN THE REGULATION OF TUMOR-DEVELOPMENT [J].
BARTOLAZZI, A ;
PEACH, R ;
ARUFFO, A ;
STAMENKOVIC, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :53-66
[10]   HYALURONAN (HYALURONIC-ACID) AND HYALURONECTIN IN THE EXTRACELLULAR-MATRIX OF HUMAN BREAST CARCINOMAS - COMPARISON BETWEEN INVASIVE AND NONINVASIVE AREAS [J].
BERTRAND, P ;
GIRARD, N ;
DELPECH, B ;
DUVAL, C ;
DANJOU, J ;
DAUCE, JP .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (01) :1-6